Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Rabies Veterinary Vaccines Market, by Region, 2020-2030 (USD Million)
1.2.2. Rabies Veterinary Vaccines Market, by Application, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Rabies Veterinary Vaccines Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Rabies Veterinary Vaccines Market Dynamics
3.1. Rabies Veterinary Vaccines Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing awareness regarding zoonotic diseases
3.1.1.2. Growing pet ownership rates
3.1.2. Market Challenges
3.1.2.1. High Storage Cost of Rabies Veterinary Vaccines
3.1.2.2. Lack of animal healthcare awareness
3.1.3. Market Opportunities
3.1.3.1. Growing technological Advancements and services
3.1.3.2. Growing government initiatives to eradicate animal rabies
Chapter 4. Global Rabies Veterinary Vaccines Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Rabies Veterinary Vaccines Market, by Application
5.1. Market Snapshot
5.2. Global Rabies Veterinary Vaccines Market by Application, Performance – Potential Analysis
5.3. Global Rabies Veterinary Vaccines Market Estimates & Forecasts by Application 2020-2030 (USD Million)
5.4. Rabies Veterinary Vaccines Market, Sub Segment Analysis
5.4.1. Companion Animals
5.4.2. Livestock Animals
5.4.3. Wildlife Animals
Chapter 6. Global Rabies Veterinary Vaccines Market, Regional Analysis
6.1. Top Leading Countries
6.2. Top Emerging Countries
6.3. Rabies Veterinary Vaccines Market, Regional Market Snapshot
6.4. North America Rabies Veterinary Vaccines Market
6.4.1. U.S. Rabies Veterinary Vaccines Market
6.4.1.1. Application breakdown estimates & forecasts, 2020-2030
6.4.2. Canada Rabies Veterinary Vaccines Market
6.5. Europe Rabies Veterinary Vaccines Market Snapshot
6.5.1. U.K. Rabies Veterinary Vaccines Market
6.5.2. Germany Rabies Veterinary Vaccines Market
6.5.3. France Rabies Veterinary Vaccines Market
6.5.4. Spain Rabies Veterinary Vaccines Market
6.5.5. Italy Rabies Veterinary Vaccines Market
6.5.6. Rest of Europe Rabies Veterinary Vaccines Market
6.6. Asia-Pacific Rabies Veterinary Vaccines Market Snapshot
6.6.1. China Rabies Veterinary Vaccines Market
6.6.2. India Rabies Veterinary Vaccines Market
6.6.3. Japan Rabies Veterinary Vaccines Market
6.6.4. Australia Rabies Veterinary Vaccines Market
6.6.5. South Korea Rabies Veterinary Vaccines Market
6.6.6. Rest of Asia Pacific Rabies Veterinary Vaccines Market
6.7. Latin America Rabies Veterinary Vaccines Market Snapshot
6.7.1. Brazil Rabies Veterinary Vaccines Market
6.7.2. Mexico Rabies Veterinary Vaccines Market
6.8. Middle East & Africa Rabies Veterinary Vaccines Market
6.8.1. Saudi Arabia Rabies Veterinary Vaccines Market
6.8.2. South Africa Rabies Veterinary Vaccines Market
6.8.3. Rest of Middle East & Africa Rabies Veterinary Vaccines Market
Chapter 7. Competitive Intelligence
7.1. Key Company SWOT Analysis
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Sanofi SA
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Recent Developments
7.3.2. Merck & Co., Inc. (MSD Animal Health)
7.3.3. Indian Immunologicals Ltd.
7.3.4. Boehringer Ingelheim International GmbH (Animal Health)
7.3.5. Zoetis Inc.
7.3.6. Virbac
7.3.7. BroadChem Philippines Biopharma Corporation
7.3.8. Elanco Animal Health Incorporated
7.3.9. Ceva Santé Animale
7.3.10. BiogénesisBagó
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
